Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label Study Article

Industry Collaboration International Collaboration

author list

  • Fisher, George A., Jr., Wolin, Edward M., Liyanage, Nilani, Lowenthal, Susan Pitman, Mirakhur, Beloo, Pommier, Rodney F., Shaheen, Montaser, Vinik, Aaron, ELECT Study Grp

authors

publication date

  • January 1, 2018

webpage

published in

author keyword

  • Carcinoid syndrome
  • Clinical trial
  • Lanreotide depot
  • Neuroendocrine tumor
  • Quality of life
  • autogel

category

keywords

  • Carcinoid syndrome
  • Clinical trial
  • Lanreotide depot
  • Neuroendocrine tumor
  • Quality of life
  • autogel

start page

  • 16

end page

  • 24

volume

  • 23

issue

  • 1